FDA clears Varian's new Helios IMRT (intensity modulated radiation therapy) software:
This article was originally published in Clinica
Varian Medical Systems has received US FDA 510(k) clearance to market a rapid new version of its inverse treatment planning software for its SmartBeam intensity modulated radiation therapy system (IMRT). The Helios 6.5 software runs on the company's Eclipse platform, which was introduced last year to expedite and improve the quality of radiation treatment planning in a Windows environment. "This new software brings all of the power, speed and industry-leading features of our Eclipse platform to the inverse treatment planning process for IMRT," said Tim Guertin, president of the Palo Alto, California firm's oncology business.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.